- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/768 - Oncolytic viruses not provided for in groups
Patent holdings for IPC class A61K 35/768
Total number of patents in this class: 855
10-year publication summary
|
45
|
56
|
104
|
105
|
109
|
114
|
67
|
86
|
58
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Deutsches Krebsforschungszentrum | 401 |
31 |
| Kalivir Immunotherapeutics, Inc. | 49 |
23 |
| Memorial Sloan-Kettering Cancer Center | 2009 |
22 |
| Transgene S.A. | 122 |
22 |
| Guangzhou Virotech Pharmaceutical Co., Ltd. | 27 |
18 |
| Ruprecht-Karls-Universität Heidelberg | 245 |
18 |
| Duke University | 3171 |
16 |
| Sillajen, Inc. | 48 |
16 |
| Mayo Foundation for Medical Education and Research | 3354 |
15 |
| Arizona Board of Regents on behalf of Arizona State University | 2870 |
15 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3273 |
15 |
| Hangzhou Converd Co., Ltd. | 35 |
13 |
| Bionoxx Inc. | 19 |
13 |
| Seneca Therapeutics, Inc. | 14 |
12 |
| National University Corporation Tottori University | 205 |
11 |
| Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 397 |
10 |
| Ottawa Hospital Research Institute | 114 |
10 |
| City of Hope | 1020 |
9 |
| Icahn School of Medicine at Mount Sinai | 1008 |
9 |
| Ruprecht-karls-universitaet Heidelberg | 19 |
9 |
| Other owners | 548 |